Jan 10, 2023, 01:00 by User Not Found

Clinical Research News | Clinical Research News will be attending the Summit for Clinical Ops Executives—SCOPE—in Orlando, Fla. from February 6-9, 2023. Here are just a few of the items from the agenda we’ve flagged so far.

Jan 9, 2023, 10:21 by

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Jan 5, 2023, 10:39 by

Jan 5, 2023, 10:35 by

Tower Cold Chain, a leading provider of pharmaceutical temperature-controlled containers, has been awarded the prestigious silver medal from EcoVadis in recognition of the continuing action made by the company towards its sustainability credentials.

Jan 5, 2023, 10:33 by

Tower Cold Chain’s latest product for smaller pharmaceutical shipments, the KTEvolution container offering protection, security, and visibility in a small box, is now available for demonstration globally, at the company’s Centres of Excellence in the EMEA, APAC and Americas regions.

Jan 5, 2023, 10:30 by

Clinical trial management solutions provider, encapsia, has announced the appointment of Francis Destin as its new Chief Operating Officer.

Jan 5, 2023, 10:29 by

Creative Diagnostics expanded its monoclonal antibodies capabilities and offerings to global customers.

Jan 5, 2023, 10:28 by

CD Bioparticles launched a range of hydrophobic interaction chromatography resins for the purification of macromolecules including adeno-associated viruses.

Jan 5, 2023, 10:28 by

STEMart has recently introduced API Impurity Identification services for global clients.

Jan 5, 2023, 01:00 by User Not Found

Clinical Research News | We spoke with clinical research leaders about their expectations for the coming year. They predicted that hybrid and decentralized trials (DCTs) would eventually become the industry standard, brick-and-mortar sites will employ flexibility to increase patient retention, and companies will rely heavily on remote patient monitoring and wearable devices to stretch their budgets and combat the looming economic downturn.

Jan 4, 2023, 15:40 by

Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.

Jan 4, 2023, 15:32 by

Curebase Celebrates Year of Growth, Organizational Maturity

Jan 3, 2023, 09:21 by User Not Found

Clinical Research News | In recent years, pharmaceutical and life science companies have leveraged real-world evidence (RWE) to maximize patient recruitment and formulate clinical trial criteria. In the latest episode of the Scope of Things podcast, Christopher Boone, Ph.D., vice president and global head of health economics and outcomes research at AbbVie, talks about the disruptive nature of RWE and its impact on clinical trial design.

Dec 29, 2022, 10:10 by

Dec 29, 2022, 10:09 by

Dec 29, 2022, 10:09 by

Dec 29, 2022, 10:09 by

Dec 29, 2022, 10:08 by

Dec 29, 2022, 10:08 by

Dec 29, 2022, 10:08 by